お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
967715

コンパニオン診断の世界市場:業界動向、市場シェア・規模・成長率・機会および予測(2020年~2025年)

Companion Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 136 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.83円
コンパニオン診断の世界市場:業界動向、市場シェア・規模・成長率・機会および予測(2020年~2025年)
出版日: 2020年12月05日
発行: IMARC Services Private Limited
ページ情報: 英文 136 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のコンパニオン診断の市場規模は、2014年から2019年の間に約15%のCAGRで拡大しました。コンパニオン診断とは、安全で効果的な医療を提供するために、対応する治療製品に関する重要な情報を提供する検査と治療の組み合わせを指します。これらの診断はまた、病気の生態と作用機序(MOA)の深い理解を提供し、医療専門家が患者に対する治療薬の潜在的な副作用またはリスクを判断するのに役立ちます。現在、コンパニオン診断は腫瘍学で広く利用されており、標的療法やオーダーメイド医療を患者に提供しています。

癌の有病率の増加は、体外診断および標的療法に対する需要の高まりと共に、世界のコンパニオン診断市場の成長を推進する主要な要因の1つとなっています。これとは別に、個別化医療(PHC)と精密医療もまた、心血管疾患、神経疾患、感染症、炎症性疾患の治療において勢いを増しており、それが市場成長を後押ししています。さらに、次世代シーケンシング(NGS)の需要の高まり、臨床試験の増加、および医薬品と診断技術の共同開発への注目の高まりが、市場の成長に貢献しています。新しいバイオマーカーの導入、コンパニオン診断の承認の増加、および新しいコンパニオン診断製品を開発するための企業間のコラボレーションの増加などが、市場成長にプラスの影響を与える要因となっています。現在、新型コロナウイルス感染症(COVID-19)の蔓延により、診断サービスプロバイダーは医療プロバイダーに検査サービスを提供しています。彼らはまた、腫瘍学治療を受けている患者の間でCOVID-19薬の有効性を検出するためにコンパニオン診断を利用しています。世界のコンパニオン診断市場は、今後5年間力強い成長を続けると見込まれています。

当レポートは世界のコンパニオン診断市場について調査しており、業界動向、市場予測、製品およびサービス・技術・適応症・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 序文

第2章 範囲と調査方法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界のコンパニオン診断市場

  • 市場概要
  • 市場実績
  • COVID-19の影響

第6章 製品およびサービス別市場

  • アッセイ、キット、試薬
  • ソフトウェアとサービス

第7章 技術別市場

  • 免疫組織化学(IHC)
  • ポリメラーゼ連鎖反応(PCR)
  • インサイチュハイブリダイゼーション(ISH)
  • リアルタイムPCR(RT-PCR)
  • 遺伝子シーケンシング
  • その他

第8章 適応症別市場

    • 主な種類
  • 神経疾患
  • 感染症
  • 心血管疾患
  • その他

第9章 エンドユーザー別市場

  • 製薬およびバイオ製薬企業
  • リファレンスラボ
  • 委託調査機関
  • その他

第10章 地域別市場

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 国別市場

第11章 SWOT分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Agilent Technologies
    • BioMerieux
    • Danaher Corporation
    • Roche Holding AG
    • Myriad Genetics Inc.
    • Siemens Healthcare
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Companion Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Companion Diagnostics Market: Sales Value (in Billion US$), 2014-2019
  • Figure 3: Global: Companion Diagnostics Market: Breakup by Product & Service (in %), 2019
  • Figure 4: Global: Companion Diagnostics Market: Breakup by Technology (in %), 2019
  • Figure 5: Global: Companion Diagnostics Market: Breakup by Indication (in %), 2019
  • Figure 6: Global: Companion Diagnostics Market: Breakup by End User (in %), 2019
  • Figure 7: Global: Companion Diagnostics Market: Breakup by Region (in %), 2019
  • Figure 8: Global: Companion Diagnostics Market Forecast: Sales Value (in Billion US$), 2020-2025
  • Figure 9: Global: Companion Diagnostics (Assays, Kits and Reagents) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 10: Global: Companion Diagnostics (Assays, Kits and Reagents) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 11: Global: Companion Diagnostics (Software and Services) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 12: Global: Companion Diagnostics (Software and Services) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 13: Global: Companion Diagnostics (Immunohistochemistry) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 14: Global: Companion Diagnostics (Immunohistochemistry) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 15: Global: Companion Diagnostics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 16: Global: Companion Diagnostics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 17: Global: Companion Diagnostics (In-situ Hybridization) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 18: Global: Companion Diagnostics (In-situ Hybridization) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 19: Global: Companion Diagnostics (Real-time PCR) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 20: Global: Companion Diagnostics (Real-time PCR) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 21: Global: Companion Diagnostics (Gene Sequencing) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 22: Global: Companion Diagnostics (Gene Sequencing) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 23: Global: Companion Diagnostics (Other Technologies) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 24: Global: Companion Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 25: Global: Companion Diagnostics (Cancer) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 26: Global: Companion Diagnostics (Cancer) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 27: Global: Companion Diagnostics (Neurological Diseases) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 28: Global: Companion Diagnostics (Neurological Diseases) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 29: Global: Companion Diagnostics (Infectious Diseases) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 30: Global: Companion Diagnostics (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 31: Global: Companion Diagnostics (Cardiovascular Diseases) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 32: Global: Companion Diagnostics (Cardiovascular Diseases) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 33: Global: Companion Diagnostics (Other Indications) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 34: Global: Companion Diagnostics (Other Indications) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 35: Global: Companion Diagnostics (Pharmaceutical & Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 36: Global: Companion Diagnostics (Pharmaceutical & Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 37: Global: Companion Diagnostics (Reference Laboratories) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 38: Global: Companion Diagnostics (Reference Laboratories) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 39: Global: Companion Diagnostics (Contract Research Organizations) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 40: Global: Companion Diagnostics (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 41: Global: Companion Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 42: Global: Companion Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 43: North America: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 44: North America: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 45: United States: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 46: United States: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 47: Canada: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 48: Canada: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 49: Asia Pacific: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 50: Asia Pacific: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 51: China: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 52: China: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2024
  • Figure 53: Japan: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 54: Japan: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2024
  • Figure 55: India: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 56: India: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2024
  • Figure 57: South Korea: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 58: South Korea: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2024
  • Figure 59: Australia: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 60: Australia: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 61: Indonesia: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 62: Indonesia: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 63: Others: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 64: Others: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 65: Europe: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 66: Europe: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 67: Germany: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 68: Germany: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 69: France: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 70: France: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 71: United Kingdom: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 72: United Kingdom: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 73: Italy: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 74: Italy: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 75: Spain: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 76: Spain: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 77: Russia: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 78: Russia: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 79: Others: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 80: Others: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 81: Latin America: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 82: Latin America: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 83: Brazil: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 84: Brazil: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 85: Mexico: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 86: Mexico: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 87: Others: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 88: Others: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 89: Middle East and Africa: Companion Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 90: Middle East and Africa: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 91: Global: Companion Diagnostics Industry: SWOT Analysis
  • Figure 92: Global: Companion Diagnostics Industry: Value Chain Analysis
  • Figure 93: Global: Companion Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Companion Diagnostics Market: Key Industry Highlights, 2019 and 2025
  • Table 2: Global: Companion Diagnostics Market Forecast: Breakup by Product & Service (in Million US$), 2020-2025
  • Table 3: Global: Companion Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2020-2025
  • Table 4: Global: Companion Diagnostics Market Forecast: Breakup by Indication (in Million US$), 2020-2025
  • Table 5: Global: Companion Diagnostics Market Forecast: Breakup by End User (in Million US$), 2020-2025
  • Table 6: Global: Companion Diagnostics Market Forecast: Breakup by Region (in Million US$), 2020-2025
  • Table 7: Global: Companion Diagnostics Market Structure
  • Table 8: Global: Companion Diagnostics Market: Key Players
目次
Product Code: SR1019O2_Report

The global companion diagnostics market grew at a CAGR of around 15% during 2014-2019. Companion diagnostics refer to a combination of tests and therapies that provide essential information about corresponding therapeutic products to deliver safe and effective medical care. These diagnostics also offer an in-depth understanding of disease biology and the mechanism of action (MOA), which help healthcare professionals determine the potential side effects or risks of a therapeutic product on the patient. At present, companion diagnostics are extensively utilized in oncology to deliver targeted therapies and personalized medicines to patients.

The growing prevalence of cancer, in confluence with the escalating demand for in-vitro diagnostics and targeted therapies, represents one of the key factors impelling the global companion diagnostics market growth. Apart from this, personalized healthcare (PHC) and precision medicine are also gaining traction in the treatment of cardiovascular, neurological, infectious and inflammatory diseases, which, in turn, is bolstering the growth of the market. Furthermore, the escalating demand for next-generation sequencing (NGS), the rising number of clinical trials and the increasing focus on the co-development of drugs and diagnostic technologies are contributing to the market growth. The introduction of new biomarkers, rising approvals of companion diagnostics and increasing collaboration between companies to develop novel companion diagnostic products are some of the other factors positively influencing the market growth. Currently, due to the spread of the coronavirus disease (COVID-19), diagnostic service providers are providing test services to healthcare providers. They are also utilizing companion diagnostics to detect the efficacy of COVID-19 drugs among patients undergoing oncology therapies. Looking forward, IMARC Group expects the global companion diagnostics market to continue its strong growth during the next five years.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global companion diagnostics market report, along with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on region, product & services, technology, indication and end-user.

Breakup by Product & Service:

  • Assays, Kits and Reagents
  • Software and Services

Breakup by Technology:

  • Immunohistochemistry (IHC)
  • Polymerase Chain Reaction (PCR)
  • In-situ Hybridization (ISH)
  • Real-time PCR (RT-PCR)
  • Gene Sequencing
  • Others

Breakup by Indication:

  • Cancer
  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • Neurological Diseases
  • Infectious Diseases
  • Cardiovascular Diseases
  • Others

Breakup by End User:

  • Pharmaceutical & Biopharmaceutical Companies
  • Reference Laboratories
  • Contract Research Organizations
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Agilent Technologies, BioMerieux, Danaher Corporation, Roche Holding AG, Myriad Genetics Inc., Siemens Healthcare and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global companion diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global companion diagnostics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product & services?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global companion diagnostics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Companion Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product & Service

  • 6.1 Assays, Kits and Reagents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Software and Services
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Immunohistochemistry (IHC)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Polymerase Chain Reaction (PCR)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 In-situ Hybridization (ISH)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Real-time PCR (RT-PCR)
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Gene Sequencing
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Indication

  • 8.1 Cancer
    • 8.1.1 Market Trends
    • 8.1.2 Major Types
      • 8.1.2.1 Lung Cancer
      • 8.1.2.2 Breast Cancer
      • 8.1.2.3 Colorectal Cancer
      • 8.1.2.4 Gastric Cancer
      • 8.1.2.5 Melanoma
      • 8.1.2.6 Others
    • 8.1.3 Market Forecast
  • 8.2 Neurological Diseases
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Infectious Diseases
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Cardiovascular Diseases
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pharmaceutical & Biopharmaceutical Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Reference Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Contract Research Organizations
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Agilent Technologies
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 BioMerieux
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Danaher Corporation
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Roche Holding AG
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Myriad Genetics Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Siemens Healthcare
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Thermo Fisher Scientific Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.